AMP Health Review
Site is down for maintenance and not taking ordersAMP Health scores below our bar on medical oversight — read the score breakdown before signing up.
Semaglutide
Tirzepatide
AMP Health: Site is down for maintenance and not taking orders. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →AMP Health offers compounded semaglutide (injectable and oral) from $199/mo and tirzepatide from $309/mo, plus a $79/mo subscription fee. Brand Wegovy listed but out of stock. 30-day satisfaction guarantee.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to AMP Health
Editorial score · methodology
Editorial score · methodology
Sprout Health
Best for: LegitScript-verified compounded GLP-1 via named pharmacies
Editorial score · methodology
AMP Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (Plus $79/mo subscription)
- FDA status
- 1 FDA warning letter on record — see below
How we scored AMP Health
Each dimension is scored algorithmically from AMP Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.4/10At $199/mo, AMP Health runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
8.0/10AMP Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.7/10Online intake and platform experience; 4 platform features disclosed.
Trust & Safety15%
5.5/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above); dispenses through an accredited compounding pharmacy (last checked 2026-08-16).
Accessibility10%
5.9/10AMP Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.7/10AMP Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this AMP Health review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with AMP Health
We walked AMP Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1A board-certified, licensed healthcare provider reviews your health history via a telehealth call (audio or video).
- 2If appropriate, the provider prescribes a GLP-1 medication.
- 3Treatment starts at a low dose and increases after about 3-4 weeks.
- 4Progress is monitored monthly with dosage adjustments as needed.
- GLP-1 weight-loss telehealth offering semaglutide and tirzepatide; medication cost is separate from the subscription.
- Stated $79.00/month subscription that includes a personal nutrition plan, ongoing check-ins, and education.
- Explicitly available only in New York and New Jersey.
- No long-term contracts or cancellation fees per the FAQ.
- At time of visit the homepage was displaying an 'under maintenance' page advertising a free first month of weight-loss medication.
GLP-1 medications AMP Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Plus $79/mo subscription
Plus $79/mo subscription
Plus $79/mo subscription
Ready to get started?
Plans and promotions change often — check AMP Health's current pricing and active discounts before you decide.
What we like
- Semaglutide in both injectable and oral formats
- Tirzepatide available
- 30-day satisfaction guarantee
- Personal nutrition plan and health coaching included
Watch-outs
- $79/mo subscription fee on top of medication ($278–$388/mo total)
- No visible LegitScript or PCAB accreditation
- No physical address disclosed
- States served not disclosed
- Brand Wegovy listed but out of stock
AMP Health, reviewed honestly: a thin offer wrapped around an open question
AMP Health pitches itself as a one-stop shop for compounded GLP-1 weight-loss medication, leading with the thing most patients want to hear about semaglutide: you can get it as a shot or as a daily oral version, and it comes bundled with a nutrition plan and health coaching. On paper that's a reasonable package. In practice, the most important fact about AMP Health right now is one the marketing won't tell you: at our last check the live site was sitting behind a maintenance page, and the parts that still worked funneled you toward a booking call rather than a real checkout. That single detail shapes everything below, so read the whole thing before you hand over a card.
What it actually sells, and how the money really works
AMP Health's lineup is straightforward: compounded semaglutide in both injectable and oral form, and compounded tirzepatide. It also lists brand-name Wegovy, but that's been showing as out of stock, so treat it as a placeholder rather than a real option. The pricing structure is where you need to slow down. The medication has a monthly cost, and then there's a separate recurring subscription fee stacked on top of it every month. That second charge is easy to miss when you're scanning a headline number, and it meaningfully raises what you actually pay. Because the site was down at our last verification, we are not posting a specific rate here — the figures the company last published are currently unconfirmable. The honest move is to get the all-in monthly total in writing, medication plus subscription, before you commit. For reference, the typical price across the providers we track sits around $169 a month for the medication itself, so use that as a sanity check when AMP quotes you.
- Two charges, not one — the medication price and a monthly subscription fee are billed separately, so budget for the combined total.
- Oral semaglutide is the genuine hook — if needles are your dealbreaker, a daily pill version is the main reason to look here.
- Brand Wegovy is listed but out of stock — don't choose AMP expecting brand-name product.
- A 30-day satisfaction guarantee is advertised — worth confirming the exact refund terms while the site is restored.
The medications and how they're dispensed
Everything weight-loss here is compounded, meaning it's mixed by a pharmacy rather than supplied as an FDA-approved branded product. Compounded semaglutide and tirzepatide are the same active ingredients found in the well-known brands, but the formulation, dosing, and quality controls depend entirely on the pharmacy behind them. And that's exactly where AMP Health goes quiet: the record we have lists no named compounding partner, no LegitScript certification, and no PCAB-accredited pharmacy. For a category where the pharmacy is the whole safety story, that's a notable blank. The oral option is the standout — a swallow-it daily formulation rather than a weekly injection — and that convenience is the clearest reason someone would pick AMP over a more transparent competitor.
The differentiator nobody advertises: the site was in maintenance mode
Here's the part that earns AMP Health its skepticism. When we went to verify its offer, the homepage was serving a maintenance page rather than a working store, promoting a 'first month free' teaser. The normal shopping route had been replaced: the product pages redirected into a phone-booking widget, the kind of call-funnel setup where a rep walks you toward signing up rather than a self-serve checkout you control. On top of that, the site's underlying code still referenced an old SlimMD logo — strong evidence that AMP Health is a rebrand of a previous operation rather than a brand-new company with the track record it implies. None of that is automatically disqualifying, but combined, it paints a picture of an offer in flux, with pricing and availability you cannot independently confirm today.
Who it's genuinely for — and who should walk
AMP Health makes the most sense for a narrow type of patient: someone set on oral semaglutide who also wants coaching and a nutrition plan folded in, and who is comfortable getting on a phone call to sort out the details. If that's you, go in with eyes open and pin down the pharmacy, the all-in price, and the refund window before paying.
You should skip it if you want transparency you can verify before you buy. There's no disclosed physical address, no published list of states served, no visible pharmacy accreditation, and — at last check — no functioning storefront. If you value brand-name product, a clear and accountable pharmacy, or simply the ability to see exactly what you're charged before committing, several providers we rank are far more upfront. The bundled subscription fee also makes AMP pricier than the bare medication number suggests, so a 'cheap' first impression can be misleading.
Trust and safety: the weakest part of the file
AMP has an FDA warning letter on record, covered in the regulatory notice below. To its credit, it advertises a satisfaction guarantee and coaching support. But trust is built on what a provider is willing to show you, and AMP shows very little: no accreditation, no address, no state disclosure, an out-of-stock brand listing, a maintenance-mode website, a booking-call funnel, and signs of a prior identity under a different name. That's a low-confidence profile. We'd want to see a named, accredited pharmacy and a working, transparent checkout before we'd rate the oversight here as reassuring. You can see how we weigh these signals in our scoring methodology.
Bottom line
AMP Health has a real selling point in oral semaglutide plus included coaching, but right now it's an offer you can't fully verify, sold through a booking call, behind a maintenance page, under what looks like a rebranded identity, with no visible pharmacy accreditation and a stacked subscription fee that inflates the true cost. If oral semaglutide is non-negotiable for you, it may be worth a cautious call — but get every number and the pharmacy name in writing first. For most people, a more transparent, accredited provider is the safer place to start.
Worth pricing against RNK Health ($197/month) and Breeze Meds ($199/month) before you commit — both sit close to AMP Health on cost and formulation.
The Bottom Line
AMP Health scores below our bar on medical oversight — read the score breakdown before signing up.
AMP Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
AMP Health received an FDA warning letter dated February 20, 2026
The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this AMP Health review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.